Astera Labs, Inc. (NASDAQ:ALAB) Shares Sold by Sycomore Asset Management

Sycomore Asset Management lessened its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 67.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 17,231 shares of the company’s stock after selling 36,481 shares during the period. Sycomore Asset Management’s holdings in Astera Labs were worth $2,282,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Comprehensive Financial Planning Inc. PA purchased a new stake in Astera Labs during the fourth quarter worth about $250,000. Entropy Technologies LP purchased a new position in Astera Labs in the fourth quarter valued at $1,742,000. Empowered Funds LLC acquired a new position in Astera Labs during the 4th quarter worth $60,000. Wilmington Savings Fund Society FSB increased its holdings in Astera Labs by 24,767.5% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 9,947 shares of the company’s stock worth $1,317,000 after purchasing an additional 9,907 shares during the period. Finally, Kingsview Wealth Management LLC raised its position in Astera Labs by 20.2% in the 4th quarter. Kingsview Wealth Management LLC now owns 7,490 shares of the company’s stock valued at $992,000 after purchasing an additional 1,260 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of several recent analyst reports. Craig Hallum increased their price target on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Barclays increased their price target on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a report on Friday, January 17th. Morgan Stanley dropped their target price on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 28th. Roth Mkm increased their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, Stifel Nicolaus lifted their price objective on Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a report on Monday, January 6th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $107.42.

Astera Labs Stock Down 3.1 %

Astera Labs stock opened at $101.29 on Monday. The firm’s fifty day moving average price is $122.39 and its 200 day moving average price is $81.91. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 197,297 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the transaction, the director now owns 6,148 shares of the company’s stock, valued at $556,455.48. This trade represents a 96.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel Philip Mazzara sold 2,513 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.81, for a total value of $228,205.53. Following the completion of the sale, the general counsel now owns 248,745 shares of the company’s stock, valued at $22,588,533.45. This trade represents a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 846,452 shares of company stock worth $86,427,256 in the last 90 days.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.